Sign in
CompletedNo phase

Sleep Chatbot Intervention for Emerging Black/African American Adults

Key facts

Who runs it
University of Delaware
Where
Newark, United StatesSee the site
Trial code
Status
Completed
People taking part
26 people enrolled
Started
4 Sept 2023
Ended
5 Feb 2025
Type of study
Interventional
Treatments tested
  • sleep chatbot
Record updated
31 July 2026

Who can take part

Age
18 years to 25 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • male or female ages 18-25 years old
  • self-identified as Black/African Americans (BAA),
  • poor sleep [Insomnia severity index (ISI) >10]
  • having at least one of the cardiometabolic risk factors on the Life's Essential 8 checklist for cardiovascular health, as defined by the American Heart Association, including health factors confirmed by fasting blood testing during the first lab visit (fasting blood glucose ≥110mg/dL, high-density lipoprotein (good cholesterol) ≤ 40 mg/dL for males and ≤ 50 mg/dL for females, triglycerides ≥150mg/dL, total cholesterol ≥200 mg/dL, blood pressure ≥130/85mmHg, waist circumference≥40 inches for males, ≥35 inches for females) or healthy behaviors such as short sleep (<7 hours), smoking or inactive (<150 minutes/week of moderate aerobic activity such as gardening, social dancing, or < 75 minutes/week of vigorous aerobic activity such as running, swimming laps, jumping rope), and (e) own a smartphone (iPhone or Android)
  • own a smartphone (iPhone or Android)

Who cannot take part

  • regular use of medications with substantial impact on sleep and cardio-metabolic markers
  • self-report medical conditions [i.e., major depressive disorder [Patient Health Questionnaire-9 (PHQ-9) ≥15)
  • alcohol abuse (Alcohol Use Disorders Identification Test--short form score ≥7 for males and ≥5 for females)
  • diagnosed obstructive apnea] that may affect sleep
  • shift worker
  • smoker
  • self-report pregnancy/lactation

Where in United States

  • University of DelawareNewark, United States

About the trial

What the trial wants to find out

Unhealthy sleep and cardiometabolic risk are two major public health concerns in emerging Black/African American (BAA) adults. Evidence-based sleep interventions such as cognitive-behavioral therapy for insomnia (CBT-I) are available but not aligned with the needs of this at-risk group. Innovative work on the development of an artificial intelligence sleep chatbot using CBT-I guidelines will provide scalable and efficient sleep interventions for emerging BAA adults.

The group in the trial

  • sleep chatbot interventionTreatment being tested

    Using CBT-I principles, participants will receive a four-week intervention delivered through a chatbot. The self-administered intervention is comprised of personalized behavioral prescriptions based on stimulus control principles and sleep schedule modification goals using sleep efficiency (SE) criteria. Participants are allowed to self-adjust expectations and make realistic decisions on sleep schedules. Other CBT-I components will be used as on-demand content. The chatbot will facilitate sleep goal setting with the participant, communicate weekly behavioral prescription and CBT-I educational modules, collect sleep diary and provide adaptive feedback and reactive services (e.g. Q\&A conversations) 24/7.

    Treatment: sleep chatbot

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Artificial Intelligence Sleep Chatbot in Emerging Black/African American Adults With Cardiometabolic Risk Factors: a Feasibility Study
Record updated
31 July 2026